Richard J. Pietras

9.5k total citations · 2 hit papers
97 papers, 7.4k citations indexed

About

Richard J. Pietras is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Richard J. Pietras has authored 97 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 41 papers in Genetics and 37 papers in Molecular Biology. Recurrent topics in Richard J. Pietras's work include Estrogen and related hormone effects (39 papers), HER2/EGFR in Cancer Research (29 papers) and Lung Cancer Treatments and Mutations (14 papers). Richard J. Pietras is often cited by papers focused on Estrogen and related hormone effects (39 papers), HER2/EGFR in Cancer Research (29 papers) and Lung Cancer Treatments and Mutations (14 papers). Richard J. Pietras collaborates with scholars based in United States, Thailand and Australia. Richard J. Pietras's co-authors include Clara M. Szego, Dennis J. Slamon, Mark D. Pegram, Diana C. Márquez‐Garbán, Diana C. Márquez, Michael C. Fishbein, Lee Goodglick, Ernest M. Wright, Hsiao‐Wang Chen and Olga K. Weinberg and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard J. Pietras

97 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells

1977 554 citations Richard J. Pietras, Clara M. Szego profile →
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

1999 540 citations Mark D. Pegram, Gail D. Lewis Phillips et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard J. Pietras United States	44	3.7k	2.9k	2.3k	1.5k	1.2k	97	7.4k
Sarah J. Parsons United States	53	3.0k 0.8×	6.3k 2.2×	808 0.3×	853 0.6×	1.0k 0.9×	117	9.7k
Simak Ali United Kingdom	55	4.2k 1.1×	7.3k 2.6×	4.8k 2.0×	354 0.2×	1.5k 1.3×	157	11.8k
Joanne Edwards United Kingdom	53	3.0k 0.8×	4.6k 1.6×	873 0.4×	544 0.4×	3.0k 2.6×	264	9.1k
Anton Wellstein United States	52	2.1k 0.6×	6.1k 2.1×	1.2k 0.5×	293 0.2×	803 0.7×	223	9.4k
Yasuhiro Miki Japan	45	2.2k 0.6×	2.8k 1.0×	2.5k 1.1×	159 0.1×	1.1k 0.9×	248	6.7k
Robert J. Matusik United States	51	1.8k 0.5×	5.7k 2.0×	2.2k 0.9×	273 0.2×	3.7k 3.2×	147	9.7k
Natasha Kyprianou United States	49	2.0k 0.5×	3.9k 1.4×	605 0.3×	336 0.2×	2.7k 2.3×	135	7.5k
Nicholas C. Popescu United States	49	1.9k 0.5×	5.6k 2.0×	948 0.4×	312 0.2×	667 0.6×	104	8.6k
Juan Carlos Lacal Spain	54	1.8k 0.5×	5.7k 2.0×	501 0.2×	785 0.5×	485 0.4×	162	8.4k
Paul S. Rennie Canada	55	1.7k 0.5×	4.9k 1.7×	2.3k 1.0×	274 0.2×	3.8k 3.2×	216	9.4k

Countries citing papers authored by Richard J. Pietras

Since Specialization

Citations

This map shows the geographic impact of Richard J. Pietras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Pietras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Pietras more than expected).

Fields of papers citing papers by Richard J. Pietras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Pietras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Pietras. The network helps show where Richard J. Pietras may publish in the future.

Co-authorship network of co-authors of Richard J. Pietras

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Pietras. A scholar is included among the top collaborators of Richard J. Pietras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Pietras. Richard J. Pietras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chan, Ann M., Vei Mah, Justin M. Balko, et al.. (2024). EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancers. 16(8). 1481–1481. 3 indexed citations

Boonyaratanakornkit, Viroj, et al.. (2017). Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Molecular and Cellular Endocrinology. 466. 51–72. 34 indexed citations

Mah, Vei, Mohammad Alavi, Diana C. Márquez‐Garbán, et al.. (2015). Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status. PLoS ONE. 10(5). e0127600–e0127600. 32 indexed citations

Garon, Edward B., Richard J. Pietras, Richard S. Finn, et al.. (2013). Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(3). 270–278. 47 indexed citations

Márquez‐Garbán, Diana C., et al.. (2012). The role of Estrogen, Progesterone and Aromatase in Human Non-Small-Cell Lung Cancer. PubMed. 1(4). 259–272. 25 indexed citations

Márquez‐Garbán, Diana C., Vei Mah, Mohammad Alavi, et al.. (2011). Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids. 76(9). 910–20. 71 indexed citations

Mah, Vei, David B. Seligson, Li Ai, et al.. (2007). Aromatase Expression Predicts Survival in Women with Early-Stage Non–Small Cell Lung Cancer. Cancer Research. 67(21). 10484–10490. 112 indexed citations

Pietras, Richard J. & Diana C. Márquez‐Garbán. (2007). Membrane-Associated Estrogen Receptor Signaling Pathways in Human Cancers. Clinical Cancer Research. 13(16). 4672–4676. 115 indexed citations

Weinberg, Olga K., Diana C. Márquez‐Garbán, Michael C. Fishbein, et al.. (2005). Aromatase Inhibitors in Human Lung Cancer Therapy. Cancer Research. 65(24). 11287–11291. 148 indexed citations

10.

Pegram, Mark D., G. Konecny, Christopher J. O’Callaghan, et al.. (2004). Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer. JNCI Journal of the National Cancer Institute. 96(10). 739–749. 395 indexed citations

11.

Pietras, Richard J.. (2003). Interactions Between Estrogen and Growth Factor Receptors in Human Breast Cancers and the Tumor-Associated Vasculature. The Breast Journal. 9(5). 361–373. 63 indexed citations

12.

Li, Dan, Jon I. Williams, & Richard J. Pietras. (2002). Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene. 21(18). 2805–2814. 63 indexed citations

13.

Pietras, Richard J., Ilka Nemere, & Clara M. Szego. (2001). Steroid Hormone Receptors in Target Cell Membranes. Endocrine. 14(3). 417–428. 59 indexed citations

14.

Pegram, Mark D., Gail D. Lewis Phillips, Richard J. Pietras, et al.. (1999). Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene. 18(13). 2241–2251. 540 indexed citations breakdown →

15.

Pietras, Richard J., et al.. (1999). Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.. PubMed. 59(6). 1347–55. 238 indexed citations

16.

Pietras, Richard J., et al.. (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.. PubMed. 10(12). 2435–46. 493 indexed citations

17.

Pietras, Richard J., et al.. (1994). Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.. PubMed. 9(7). 1829–38. 362 indexed citations

18.

Pietras, Richard J., et al.. (1978). Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure.. PubMed. 52(3). 321–7. 35 indexed citations

19.

Pietras, Richard J., et al.. (1976). Differential effects of vasopressin on the water, calcium and lysosomal enzyme contents of mitochondria-rich and lysosome-rich (granular) epithelial cells isolated from bullfrog urinary bladder. Molecular and Cellular Endocrinology. 4(2). 89–106. 18 indexed citations

20.

Pietras, Richard J. & Clara M. Szego. (1975). Surface Modifications Evoked by Estradiol and Diethylstilbestrol in Isolated Endometrial Cells: Evidence from Lectin Probes and Extracellular Release of Lysosomal Protease. Endocrinology. 97(6). 1445–1454. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact